Kroopa Joshi
Royal Free London NHS Foundation Trust · 47 works · 4,735 citations · h-index 18
Top works
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
- Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
- Neoantigen-directed immune escape in lung cancer evolution
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- Pan-cancer deconvolution of tumour composition using DNA methylation
- Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
- Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
- Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and Versatile
- The T cell differentiation landscape is shaped by tumour mutations in lung cancer
- Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
- The impact of effective systemic therapies on surgery for stage IV melanoma
- Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer
- Cytokine release syndrome in solid tumours: mechanism-based therapeutic strategies for prevention and management
- Abstract PO3-17-12: Safety and efficacy of Atezolizumab in combination with nab-Paclitaxel in patients with PD-L1 positive metastatic or locally advanced triple-negative breast cancer: A pan-UK cancer centre experience
- An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood
- Evolving adoptive cellular therapies in urological malignancies
- Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy
- Quantitative analysis of the T cell receptor repertoire
- Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma